Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRTX NASDAQ:MGRX NYSE:SSY NASDAQ:VSEE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXBiorestorative Therapies$1.41-4.1%$1.66$1.21▼$2.55$10.58M76.73104,921 shs31,960 shsMGRXMangoceuticals$1.71+1.8%$1.80$1.32▼$7.66$8.84M2.41143,189 shs53,827 shsSSYSunLink Health Systems$1.04-2.8%$1.00$0.62▼$1.91$7.32M1.11137,328 shs46,642 shsVSEEVSee Health$1.21-6.2%$1.20$1.00▼$6.34N/AN/AN/A50,588 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXBiorestorative Therapies0.00%-12.96%-10.98%-23.37%-7.84%MGRXMangoceuticals0.00%-1.16%+10.68%+1.79%-98.14%SSYSunLink Health Systems0.00%-23.53%+17.38%+19.54%+16.99%VSEEVSee Health0.00%-9.02%+3.42%-0.41%-48.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRTXBiorestorative Therapies3.5083 of 5 stars3.55.00.00.00.03.30.6MGRXMangoceuticalsN/AN/AN/AN/AN/AN/AN/AN/ASSYSunLink Health Systems1.7131 of 5 stars0.03.00.00.02.41.71.9VSEEVSee Health1.3523 of 5 stars2.04.00.00.01.10.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRTXBiorestorative Therapies 3.00Buy$18.001,176.60% UpsideMGRXMangoceuticals 0.00N/AN/AN/ASSYSunLink Health Systems 0.00N/AN/AN/AVSEEVSee Health 4.00Strong Buy$5.00313.22% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRTXBiorestorative Therapies$400K26.44N/AN/A$1.23 per share1.15MGRXMangoceuticals$620K14.26N/AN/A$4.30 per share0.40SSYSunLink Health Systems$31.09M0.24N/AN/A$2.00 per share0.52VSEEVSee HealthN/AN/AN/AN/A($3.40) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRTXBiorestorative Therapies-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)MGRXMangoceuticals-$8.71M-$4.64N/A∞N/A-2,191.76%-72.81%-66.58%8/13/2025 (Estimated)SSYSunLink Health Systems-$1.53M$0.247.43∞N/A3.20%-20.94%-16.09%N/AVSEEVSee Health-$4.41MN/A0.00∞N/AN/AN/AN/A9/22/2025 (Estimated)Latest VSEE, BRTX, SSY, and MGRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025BRTXBiorestorative Therapies-$0.41N/AN/AN/A$0.34 millionN/A5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 million5/14/2025Q1 2025BRTXBiorestorative Therapies-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRTXBiorestorative TherapiesN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/AVSEEVSee HealthN/AN/AN/AN/AN/ALatest VSEE, BRTX, SSY, and MGRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/21/2025SSYSunLink Health Systemsspecial$0.107/29/20257/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRTXBiorestorative TherapiesN/A2.242.24MGRXMangoceuticalsN/A0.120.12SSYSunLink Health SystemsN/A4.063.62VSEEVSee HealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRTXBiorestorative Therapies69.38%MGRXMangoceuticals56.72%SSYSunLink Health Systems23.67%VSEEVSee Health1.01%Insider OwnershipCompanyInsider OwnershipBRTXBiorestorative Therapies25.50%MGRXMangoceuticals16.00%SSYSunLink Health Systems27.90%VSEEVSee Health6.59%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRTXBiorestorative Therapies77.50 million5.59 millionNot OptionableMGRXMangoceuticals35.17 million4.34 millionNot OptionableSSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableVSEEVSee HealthN/A3.60 million3.37 millionN/AVSEE, BRTX, SSY, and MGRX HeadlinesRecent News About These CompaniesCORRECTING and REPLACING VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 16, 2025 | businesswire.comVSee Health stock soars after launching AI doctor notes solutionJuly 14, 2025 | in.investing.comVSee Health Stock Jumps After Unveiling AI-Powered Doctor Notes ToolJuly 14, 2025 | msn.comVSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 14, 2025 | businesswire.comVSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare MarketJune 26, 2025 | theglobeandmail.comVSee Health selected for NIH-funded stroke recovery telerehab trialJune 25, 2025 | investing.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial - Business WireJune 24, 2025 | businesswire.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical TrialJune 23, 2025 | businesswire.comVSee Health faces Nasdaq compliance issue over late filingsJune 1, 2025 | investing.comVSee Health faces Nasdaq delisting over late filingJune 1, 2025 | uk.investing.comVSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q FilingMay 30, 2025 | businesswire.comVSee Health launches telehealth initiative in the PhilippinesMay 17, 2025 | investing.comVSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote PhilippinesMay 16, 2025 | businesswire.comVSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K FilingMay 12, 2025 | businesswire.comVSee Health Inc. Faces Nasdaq Delisting Over Late FilingMay 10, 2025 | investing.comVSee Health unveils AI-driven telenursing platformApril 18, 2025 | uk.investing.comVSee Unveils Advanced Telenursing Robotics Solution Targeting 3-5% Reduction in Hospital Nursing CostsApril 16, 2025 | finance.yahoo.comVSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market Featured Image featured image Admin MessageApril 2, 2025 | markets.businessinsider.comVSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare MarketApril 2, 2025 | prnewswire.comVSee Health issues letter to shareholders updating progressMarch 7, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVSEE, BRTX, SSY, and MGRX Company DescriptionsBiorestorative Therapies NASDAQ:BRTX$1.41 -0.06 (-4.08%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.42 +0.01 (+0.71%) As of 08/1/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.Mangoceuticals NASDAQ:MGRX$1.71 +0.03 (+1.79%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.68 -0.03 (-2.05%) As of 08/1/2025 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.SunLink Health Systems NYSE:SSY$1.04 -0.03 (-2.80%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.12 +0.09 (+8.17%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.VSee Health NASDAQ:VSEE$1.21 -0.08 (-6.20%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.33 +0.12 (+9.92%) As of 08/1/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
